Table 3.
Hazard ratios (95%CIs) for all-cause mortality between new users of proton pump inhibitors compared to histamine 2 receptor antagonists in a secondary analysis
|
Outcome
|
PPI-users
(n = 44834) |
H2RA-users
(n = 44834) |
HR (95%CI)
|
| At 1-year | 8393 | 7980 | 1.51 (1.41-1.69) |
| At 2-years | 12950 | 11989 | 1.16 (1.04-1.39) |
| Overall outcome during follow-up | 18304 | 17146 | 1.17 (1.05-2.16) |
PPI: Proton pump inhibitor; HR: Hazard ratio; H2RA: Histamine2 receptor antagonist.